Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Tr
scientific article
Author/s
author: Scott D Berkowitz, Graeme J. Hankey, Robert Califf, Kenneth W Mahaffey, Jonathan P. Piccini, Jonathan L. Halperin, Günter Breithardt, Yuliya Lokhnygina, Daniel E. Singer, Manesh Patel, Keith Fox, Christopher C Nessel, ROCKET AF Steering Committee and Investigators, Susanna R Stevens, Jeffrey B Washam
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.